Intralesional cidofovir for recurrent respiratory papillomatosis in children.
about
Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosisSerial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.Histopathologic effects of cidofovir on cartilage.Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis.Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management.Intralesional Cidofovir application in recurrent laryngeal papillomatosis.Pediatric bronchoscopy.Endobronchial tumors in children: an uncommon clinical entity.HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial.Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir.Pharmacotherapy of recurrent respiratory papillomatosis.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Recurrent respiratory papillomatosis: current and future perspectives.The use of antiviral drugs during the neonatal periodRecurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.Office-based Management of Recurrent Respiratory Papilloma.Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature.Recurrent respiratory papillomatosis: a review.Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis.Site of infections associated with human papillomavirus.Successful treatment of squamous cell carcinoma of the lower eyelid with intralesional cidofovir.Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.Viral diseases of the skin: diagnosis and antiviral treatment.Local and systemic effects of intralaryngeal injection of cidofovir in a canine model.Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.Human papilloma virus papilloma masquerading as adenoid hypertrophy.Topical 1% cidofovir for the treatment of vulvar intraepidermal neoplasia (VIN1) developed on lichen sclerosus.Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity.Coblation resection of paediatric laryngeal papilloma.
P2860
Q24649849-7121C908-9AD2-4655-B9EF-E189BE63CB1AQ31131924-DB5D40A9-3488-4C05-A91F-FED3E36CA853Q33226759-C9CAA1E2-FBA6-4DEC-8691-DE083C006E9CQ33229640-5357CD66-4728-4467-85A1-23125BF7EC74Q33259401-5D7577E9-B1A3-4C7D-8A3B-6D1FF4E92497Q33261181-16924915-CFA5-45A6-8BA5-0230CF0A8032Q34141822-F9404CE2-4172-4C11-8AA6-7C21A5B53B31Q34153482-84734CE1-01A6-4A91-86D3-4A74F188F97FQ34461719-3BD05A0A-74E4-4317-81FF-CEF9288B0AF9Q34711382-62903341-5DB1-43DE-A6B4-03E533714C80Q34768490-88517128-DFE2-4334-B01E-31D36404D45AQ35558801-40E326A0-2440-4B8C-8E48-733FE54EC423Q35592876-E89BD8C9-BAC5-4D0D-B46D-0F827E2DD497Q35789702-79434923-5379-4F08-A946-7860E4A07D53Q35932976-12DA761F-07C3-4097-96F4-7D2A20393C3EQ36034606-25FBED37-344E-4E61-9640-C9583251D7F3Q36188323-A05D2143-2DBA-49C1-AF25-C51536CEAFEFQ36840035-6D111350-E3C4-43D6-90D4-8561D320943BQ37170198-48FE9003-0B00-4947-B685-4BD35A794FBBQ37849276-4CB77895-EC4D-4DFF-8B0D-5DF6DF6569F0Q38253253-31A60151-9DCA-4FF3-9211-FBC6D81D2685Q43009356-D1A56B39-0218-4390-BE34-BA033AE58AC0Q43142008-59AA6B08-B919-4714-AE9C-52C9EF2AE0DFQ43871005-EDE2090E-1BB1-4BAD-8710-005E711A47D2Q44645733-025E43C8-54D2-4D0D-8352-59AE3B7D0823Q44974683-BE7A9820-FB7C-4BCD-9FBE-A4E0F28763D6Q45189384-A755C0FF-0594-43F0-A3DA-DC413385A80DQ45428770-28B1D061-535A-4208-AB39-2B25B92BDC35Q46025059-9DA7BDB9-ECA5-4461-8698-7A5CB188D386Q46431975-12AD0018-F999-4984-9E79-3FA3B1CC3D3DQ46857637-956D232B-22FD-465E-AA96-B2072688D647Q48255868-70021F97-C27D-4A1C-A0F6-11AF3E7DD4BC
P2860
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@ast
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@en
type
label
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@ast
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@en
prefLabel
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@ast
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@en
P2093
P1433
P1476
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
@en
P2093
P304
P356
10.1001/ARCHOTOL.125.10.1143
P577
1999-10-01T00:00:00Z